Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

1
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

1
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

320
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
320
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

527
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
527

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise training for cardiovascular prevention in patients with cancer.

European heart journal·2026
Same author

Weekly Journal Scan: Discontinuation due to adverse events varies across antihypertensive regimens.

European heart journal·2026
Same author

Left ventricular excessive trabeculation: pathophysiology, diagnostic challenges, and prognostic significance.

Heart failure reviews·2026
Same author

Prognostic impact of chronotropic incompetence in transthyretin cardiac amyloidosis: a multicentre study.

ESC heart failure·2026
Same author

Prevention of Heart Failure in Women: An Expert Consensus Statement on Sex-Specific Risk Factors.

European journal of heart failure·2026
Same author

Beyond the slope: prognostic utility of the VE/VCO<sub>2</sub> intercept in chronic heart failure.

Open heart·2026

Related Experiment Video

Updated: Jun 9, 2025

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.3K

Chronotropic incompetence across heart failure categories.

Damiano Magrì1, Massimo Piepoli2,3, Giovanna Gallo1

  • 1Department of Clinical and Molecular Medicine, Sapienza University of Rome, Via di Grottarossa 1035-1039, 00199 Rome, Italy.

European Journal of Preventive Cardiology
|October 27, 2024
PubMed
Summary

Chronotropic incompetence (CI) in heart failure (HF) is linked to poor exercise capacity and outcomes. Understanding CI definitions and management strategies is crucial for improving patient prognosis.

Keywords:
Chronotropic incompetenceHeart failureHeart rate response

More Related Videos

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.5K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.4K

Related Experiment Videos

Last Updated: Jun 9, 2025

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.3K
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.5K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.4K

Area of Science:

  • Cardiology
  • Autonomic Nervous System Research
  • Heart Failure Pathophysiology

Background:

  • Heart failure (HF) syndrome involves autonomic imbalance and sympathetic hyperactivity.
  • This leads to increased myocardial oxygen demand, oxidative stress, and peripheral vasoconstriction.
  • Progressive desensitization and downregulation of cardiac β1-receptors contribute to HF pathophysiology.

Purpose of the Study:

  • To review definitions and clinical impact of chronotropic incompetence (CI) in heart failure.
  • To discuss pharmacological and non-pharmacological therapeutic strategies for CI.
  • To clarify the interference of certain medications with exercise-induced heart rate response.

Main Methods:

  • Literature review on chronotropic incompetence definitions and impact.
  • Analysis of pharmacological effects on heart rate response in HF.
  • Discussion of therapeutic interventions for managing CI.

Main Results:

  • Chronotropic incompetence (CI), defined as the inability to increase heart rate (HR) with activity, is associated with reduced exercise capacity and worse prognosis in HF.
  • Pharmacological agents, particularly beta-blockers, can interfere with physiological HR response but improve HF outcomes.
  • Rate-adapting pacing is a debated strategy to manage blunted exercise-induced HR response.

Conclusions:

  • CI is a significant clinical finding in HF, impacting exercise capacity and prognosis.
  • Careful consideration of medications like beta-blockers is essential, as their benefits outweigh potential HR blunting.
  • Further research into effective therapeutic strategies for CI is warranted.